provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content

Cabenuva

cabotegravir / rilpivirine
Used for HIV Treatment
Used for HIV Treatment

Cabenuva (cabotegravir / rilpivirine) is a long-acting prescription medication used to treat a human immunodeficiency virus (HIV) infection. It's injected into the gluteal muscle (buttocks) by a healthcare provider and is dosed either once a month or every other month. Cabenuva (cabotegravir / rilpivirine) is the first FDA-approved long-acting injection that offers a complete HIV-1 treatment. The most common side effects of this medication are injection site reactions, such as pain, tenderness, a hardened lump, and swelling at the buttocks muscle.

Last reviewed on April 27, 2023
basics-icon

What is Cabenuva (cabotegravir / rilpivirine)?

What is Cabenuva (cabotegravir / rilpivirine) used for?

  • HIV treatment

How Cabenuva (cabotegravir / rilpivirine) works

Cabenuva (cabotegravir / rilpivirine) is a combination of 2 medications:

  • Cabotegravir is an integrase inhibitor. Integrase is an enzyme (protein) that the HIV virus uses to enter your cells and make more copies of itself. Cabotegravir works by blocking integrase, therefore preventing HIV viruses from spreading.

  • Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It blocks an enzyme called reverse transcriptase, which prevents the HIV virus from making copies of itself and spreading.

Are you looking for information on Apretude (cabotegravir) injection, Vocabria (cabotegravir) tablet, or Edurant (rilpivirine) tablet instead?

Drug Facts

Common BrandsCabenuva
Drug ClassAntiretroviral
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
basics-icon

What are the side effects of Cabenuva (cabotegravir / rilpivirine)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

  • Injection-site reactions (pain, harden skin, local swelling; 75-83%)
  • Fever (8%)
  • Higher creatine phosphokinase levels (8%)
  • Higher pancreas enzyme levels, suggesting pancreas irritation (5%)
  • Feeling tired (5%)
  • Headache (4%)

Other Side Effects

  • Muscle or bone pain
  • Nausea
  • Trouble sleeping
  • Dizziness
  • Rash

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Suicidal thoughts and behaviors
  • Serious allergic reactions: mouth sores, trouble breathing, rash, fever, swelling in your face, lips, or tongue
  • Liver problems: feeling sleepy, upper right stomach pain, yellowing of the skin or whites of the eyes, dark urine, nausea

Source: DailyMed

The following side effects have also been reported

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue
  • Rash, fever, and swollen lymph nodes
  • Severe back pain, chest pain, headache, trouble breathing after injection
  • Thoughts of suicide or self-harm, worsening mood, feelings of depression

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

pros-and-cons

Pros and cons of Cabenuva (cabotegravir / rilpivirine)

thumbs-up

Pros

Typically needs to be injected once every 1 to 2 months, so it's convenient for people with a busy schedule

Can be used in people with kidney and liver problems

The first and only long-acting, complete HIV injectable medication

thumbs-down

Cons

Interacts with a lot of medications such as carbamazepine (Tegretol), phenytoin (Dilantin), and rifampin (Rifadin)

Unknown if safe or works well in children under 12

Likely to cause post-injection reactions

pharmacist-tips

Pharmacist tips for Cabenuva (cabotegravir / rilpivirine)

pharmacist
  • Each Cabenuva (cabotegravir / rilpivirine) treatment contains two injections, which can be injected into the muscle on each side of your buttocks or on the same side (at least 2 cm apart). Most commonly, you'll receive this medication at a hospital or a provider's office.

    • If you're switching from oral Vocabria (cabotegravir) and Edurant (rilpivirine) tablets to Cabenuva (cabotegravir / rilpivirine) injections, follow your provider's instructions on how to make the transition. Typically you can receive your first treatment of Cabenuva (cabotegravir / rilpivirine) along with the last Vocabria (cabotegravir) and Edurant (rilpivirine) tablets.

      • Be sure to plan for some extra time after your appointment. Your provider will need to monitor you for post-injection reactions after you've received Cabenuva (cabotegravir / rilpivirine). Signs and symptoms usually get better after a few minutes. But tell your provider if you experience tightness in your throat, stomach pain, sweating, trouble breathing, mouth feeling numb, back and chest pain, or dizziness.

        • Cabenuva (cabotegravir / rilpivirine) can interact with many medications. Let your provider or pharmacist know what medications you're taking, including over-the-counter products and supplements, before you start Cabenuva (cabotegravir / rilpivirine). Talk with your provider or pharmacist if you have any questions about interactions with this medication.

          • Tell your provider if you or your child experiences any changes in weight while taking Cabenuva (cabotegravir / rilpivirine). It's not clear whether this medication will be safe for or will work well for people who weigh less than 77 lbs. Let your provider know if you or your child has nausea, vomiting, or diarrhea that won’t go away since this can also be a cause of weight loss.

            • Make sure to get your routine blood tests done on time while you’re receiving Cabenuva (cabotegravir / rilpivirine) so your provider can make sure this medication is working for you and not causing side effects. Talk with your provider about your medical history, including any liver problems or history of hepatitis, before starting Cabenuva (cabotegravir / rilpivirine).

              • Let your provider know if you experience symptoms of depression or worsening mood while receiving Cabenuva (cabotegravir / rilpivirine). In cases of serious depression, your provider might ask you to stop taking this medication.

                • It's best to get your Cabenuva (cabotegravir / rilpivirine) injections around the same time every month or every other month. If you miss or are planning to miss a treatment, talk with your provider right away about rescheduling your appointment. Depending on when your next scheduled appointment is, your provider might ask you to take other HIV treatment in the meanwhile.

                  faqs

                  Frequently asked questions about Cabenuva (cabotegravir / rilpivirine)

                  Who can use Cabenuva (cabotegravir / rilpivirine)?
                  Ask your provider to see if Cabenuva (cabotegravir / rilpivirine) is an appropriate HIV treatment for you. Typically, Cabenuva (cabotegravir / rilpivirine) can only be used by people who meet the following requirements: 1) Age 12 years and older; 2) Weighs 77 lbs or more; 3) Undetectable viral load (less than 50 copies/mL); and 4) No history of cabotegravir or rilpivirine not working.
                  How is Cabenuva (cabotegravir / rilpivirine) administered?
                  You'll receive Cabenuva (cabotegravir / rilpivirine) as two injections (cabotegravir and rilpivirine) into the buttocks muscle either once a month or every other month. Before your first treatment of Cabenuva (cabotegravir / rilpivirine), your provider might prescribe oral Vocabria (cabotegravir) and Edurant (rilpivirine) tablets for about a month. This is because Cabenuva (cabotegravir / rilpivirine) is a long-acting medication that might stay in your body for 12 months or longer. Giving you oral tablets beforehand can help the provider make sure your body reacts well to cabotegravir and rilpivirine (which are the same ingredients in Cabenuva). Once you've started receiving routine Cabenuva (cabotegravir / rilpivirine) injections, you won't have to take any more daily HIV tablets.
                  Does Cabenuva (cabotegravir / rilpivirine) cure HIV?
                  No, Cabenuva (cabotegravir / rilpivirine) isn't a cure for HIV. Currently, all available medications for HIV only lower the amount of virus in the body (viral load). However, keep in mind that HIV medications, such as Cabenuva (cabotegravir / rilpivirine), can help you stay healthy by keeping your immune system working. In addition, HIV medications can also lower the risk of transmitting viruses to other people through sex or pregnancy. If you have concerns about HIV medications, talk with your provider to determine the best treatment plan.
                  How well does Cabenuva (cabotegravir / rilpivirine) work for HIV infection?
                  Studies showed that 90% of people who took Cabenuva (cabotegravir / rilpivirine) had undetectable viral loads 12 months after they started treatment. These results are similar for people who took daily HIV tablets. In addition, Cabenuva (cabotegravir / rilpivirine) worked equally well in the once-a-month and once-every-other-month regimen. If you have any questions about whether Cabenuva (cabotegravir / rilpivirine) is right for you, follow up with your provider for more information.
                  What are injection-site reactions from Cabenuva (cabotegravir / rilpivirine)?
                  Cabenuva (cabotegravir / rilpivirine) can cause pain, tenderness, a hardened lump, swelling, redness, itching, bruising, and warmth at the injection site at the buttocks muscle. About 75-83% of people who receive Cabenuva (cabotegravir / rilpivirine) have experienced some injection-site reactions, but most symptoms are mild to moderate. These reactions typically last about 3 days and get better as you continue with treatment, so let your provider know if they continue to bother you.
                  How many days can you miss your Cabenuva (cabotegravir / rilpivirine) injections?
                  It's very important to receive Cabenuva (cabotegravir / rilpivirine) regularly according to your provider's treatment plan. Missing doses can make it easier for HIV virus to change form, causing Cabenuva (cabotegravir / rilpivirine) to stop working. It also allows the virus to grow and spread in your body. If you missed a dose and it's within 7 days of the usual time you receive it, talk with your provider immediately about rescheduling your appointment as soon as possible. If you plan to miss a scheduled dose by more than 7 days, your provider might switch you to oral Vocabria (cabotegravir) and Edurant (rilpivirine) tablets until you're able to receive Cabenuva (cabotegravir / rilpivirine) injection (for up to 2 months). If you've already missed your injection by more than 7 days, discuss your treatment options with your provider.
                  Can I receive Cabenuva (cabotegravir / rilpivirine) if I'm pregnant or breastfeeding?
                  Cabenuva (cabotegravir / rilpivirine) hasn’t been well-studied in human pregnancies. However, research of dolutegravir (Tivicay), a medication similar to Cabenuva (cabotegravir / rilpivirine), showed that it caused serious birth defects to unborn babies during early pregnancy. Keep in mind that Cabenuva (cabotegravir / rilpivirine) can stay in your body for 12 months after your last injection. If you become pregnant while receiving Cabenuva (cabotegravir / rilpivirine), you’re encouraged to enroll in the Antiretroviral Pregnancy Registry (APR). This registry monitors and collects information about your and your baby’s health. Learn more about this registry by calling 1-800-258-4263. Similarly, it's not clear whether Cabenuva (cabotegravir / rilpivirine) is safe to use while breastfeeding. In general, it's recommended that you don't breastfeed your baby if you have HIV. Doing so can raise the risk of spreading the infection to your baby or cause your baby to develop a resistance to Cabenuva (cabotegravir / rilpivirine) (meaning it won't work as well for them). Speak to your provider so you can discuss the benefits and risks of receiving this medication while breastfeeding.
                  GoodRxEducationalIcon

                  How to save using GoodRx

                  Compare Prices
                  1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
                  Select your free coupon
                  2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
                  Show coupon to your pharmacist
                  3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
                  Get free couponLearn more
                  warings-icon

                  What are the risks and warnings for Cabenuva (cabotegravir / rilpivirine)?

                  Cabenuva (cabotegravir / rilpivirine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

                  risk-warning

                  Serious allergic reactions

                  People who receive Cabenuva (cabotegravir / rilpivirine) can sometimes experience a serious post-injection reaction. Your risk might be higher if your IM injection was too fast. Most of the time, reactions are mild and usually go away within a couple of minutes after the injection. Your provider will monitor you for post-injection reactions each time you receive Cabenuva (cabotegravir / rilpivirine) to make sure this medication is safe for you. In addition, HIV treatments containing rilpivirine have caused allergic reactions that are sometimes life-threatening. This is why your provider might ask you to take a tablet form of this medication before the long-acting injection form to see how you tolerate it. Watch out for signs and symptoms of allergic reactions, such as rash, trouble breathing, fever, general discomfort, tiredness, dizziness, mouth sores, pink eye, dark urine, or swelling in your face. Get medical attention right away if an allergic reaction occurs.

                  risk-warning

                  Liver problems

                  • Risk factor: Past liver problems

                    Rarely, Cabenuva (cabotegravir / rilpivirine) can cause serious liver problems. Your risk might be higher if you have had past liver problems. Talk with your provider about your medical history before starting this medication so they can decide how you can safely take Cabenuva (cabotegravir / rilpivirine). You’ll need to get blood tests done while you take Cabenuva (cabotegravir / rilpivirine) so your provider can check your liver health. If you experience signs and symptoms of liver damage, such as feeling sleepy, upper right stomach pain, yellowing of the skin or whites of the eyes, or dark urine, talk with your provider right away.

                    risk-warning

                    Depression and suicidal thoughts

                    Some people have experienced depression, mood swings, and suicidal thoughts or attempt(s) while taking Cabenuva (cabotegravir / rilpivirine). If you notice any mood changes, call your provider so they can determine if your symptoms are related to this medication. They'll also decide whether Cabenuva (cabotegravir / rilpivirine) is still safe for you to continue taking.

                    risk-warning

                    Worsening of HIV infection (with missed doses)

                    It's very important to get your Cabenuva (cabotegravir / rilpivirine) injections regularly according to your provider's treatment plan. Missing doses frequently can make it easier for HIV virus to change form, causing Cabenuva (cabotegravir / rilpivirine) to stop working. It can also lead to a higher amount of HIV virus in your body and your infection getting worse. Tell your provider right away if you miss or plan to miss a scheduled appointment to receive your injections so that they can let you know about other options.

                    If you chose to stop receiving Cabenuva (cabotegravir / rilpivirine) or if the amount of HIV virus in your blood has gone up, your provider can help you decide on a new HIV treatment plan. If you choose to start a different HIV treatment, make sure to start it within 1 to 2 months of your final Cabenuva (cabotegravir / rilpivirine) injection (depending on if you had been receiving monthly or bimonthly injections). If you wait too long to start a new treatment, you're at higher risk for for worsening HIV infection.

                    risk-warning

                    Interaction with other medications

                    Some medications can interfere with how your body removes Cabenuva (cabotegravir / rilpivirine). This can affect the amount of Cabenuva (cabotegravir / rilpivirine) in your body, how well it works, and the risk of side effects.

                    Taking medications like clarithromycin or erythromycin can raise the amount of rilpivirine in your body and raise your risk for serious heart problems. If you need to take a macrolide antibiotic, discuss with your provider whether azithromycin (Zithromax) is a better option since it has fewer interactions with Cabenuva (cabotegravir / rilpivirine).

                    Taking certain medications for seizures (e.g., carbamazepine (Tegretol), phenytoin (Dilantin), dexamethasone (more than one dose), St John’s wort, or antibiotics (e.g., rifampin (Rifadin), Priftin (rifapentine)) along with Cabenuva (cabotegravir / rilpivirine) should also be avoided. This is because these medications can lower the amount of Cabenuva (cabotegravir / rilpivirine) in your body and cause it to not work as well.

                    Cabenuva (cabotegravir / rilpivirine) also interferes with how your body removes other medications. For example, taking this medication with methadone (Methadose) can change the amount of pain medication that your body absorbs.

                    Let your provider or pharmacist know what other medications you’re taking before and while taking Cabenuva (cabotegravir / rilpivirine).

                    dosage

                    Cabenuva (cabotegravir / rilpivirine) dosage forms

                    Typical dosing for Cabenuva (cabotegravir / rilpivirine)

                    Cabenuva (cabotegravir / rilpivirine) is usually given in a hospital setting or at your provider's office by a healthcare professional. The dose of Cabenuva (cabotegravir / rilpivirine) depends on how often you receive the injections.

                    In general, for people 12 years and older who weigh 77 lbs or more:

                    • Once-a-month dosing: The typical starting dose is 2 injections (600 mg of cabotegravir and 900 mg of rilpivirine) injected into the buttocks muscle (IM) for the first month. Afterwards, the typical dose is 2 IM injections (400 mg of cabotegravir and 600 mg of rilpivirine) once a month.

                    • Every-other-month dosing: The typical starting dose is 2 injections (600 mg of cabotegravir and 900 mg of rilpivirine) injected into the buttocks muscle once a month for the first 2 months. Afterwards, the typical dose is 2 IM injections (600 mg of cabotegravir and 900 mg of rilpivirine) once every other month starting at month 4.

                    Please note: your provider might prescribe oral Vocabria (cabotegravir) and Edurant (rilpivirine) tablets for about a month before receiving Cabenuva (cabotegravir / rilpivirine) injections. Please read the FAQ section for details.

                    contraindications-icon

                    Cabenuva (cabotegravir / rilpivirine) contraindications

                    Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Cabenuva (cabotegravir / rilpivirine) will not be safe for you to take.
                    alternatives

                    What are alternatives to Cabenuva (cabotegravir / rilpivirine)?

                    There are a number of medications that your doctor can prescribe in place of Cabenuva (cabotegravir / rilpivirine). Compare a few possible alternatives below.
                    Cabenuva (cabotegravir / rilpivirine)
                    Used for:
                    • HIV treatment

                    Used for:
                    • HIV treatment

                    $10848.17 Lowest GoodRx priceView Prices
                    Used for:
                    • HIV treatment for people who are well controlled on an HIV ARV regimen already and want to switch regimens

                    $3558.28 Lowest GoodRx priceView Prices

                    Get savings updates for Cabenuva (cabotegravir / rilpivirine)

                    Receive price alerts, news, and other messages from GoodRx about Cabenuva (cabotegravir / rilpivirine) and other healthcare topics and relevant savings offers.

                    By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

                    References

                    Best studies we found

                    Centers for Disease Control and Prevention. (2023). HIV treatment as prevention.

                    Clinical Info HIV.gov. (n.d.). Integrase strand transfer inhibitor (INSTI).

                    Clinical Info HIV.gov. (n.d.). Non-nucleoside reverse transcriptase inhibitor (NNRTI).

                    View All References (5)

                    HIV.gov. (2023). Taking your HIV medicine as prescribed.

                    MedlinePlus. (n.d.). Creatine phosphokinase test.

                    U.S. Food and Drug Administration. (2021). FDA approves Cabenuva and Vocabria for the treatment of HIV-1 infection.

                    ViiV Healthcare Company. (2023). Cabenuva- cabotegravir and rilpivirine [package insert]. DailyMed.

                    ViiV Healthcare. (n.d.). About Cabenuva.

                    GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.
                    Was this page helpful?

                    Browse medications

                    View All

                    Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.